| Drug Type Small molecule drug | 
| Synonyms- | 
| Target | 
| Action inhibitors | 
| Mechanism 30S subunit inhibitors(30S ribosomal subunit inhibitors), DHFR inhibitors(Dihydrofolate reductase inhibitors) | 
| Therapeutic Areas | 
| Active Indication | 
| Inactive Indication- | 
| Originator Organization | 
| Active Organization | 
| Inactive Organization- | 
| License Organization- | 
| Drug Highest PhaseApproved | 
| First Approval Date China (01 Jan 1995),  | 
| Regulation- | 
| Molecular FormulaC14H18N4O3 | 
| InChIKeyIEDVJHCEMCRBQM-UHFFFAOYSA-N | 
| CAS Registry738-70-5 | 
| Indication | Country/Location | Organization | Date | 
|---|---|---|---|
| Infectious Diseases | China  | 01 Jan 1995 | |
| Escherichia Coli Infections | China  | - | - | 
| Gram-Negative Bacterial Infections | China  | - | - | 
| Gram-Positive Bacterial Infections | China  | - | - | 
| Pseudomonas Infections | China  | - | - | 
| Staphylococcal Infections | China  | - | - | 





